| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CALC | CalciMedica, Inc. | Sanderling Venture Partners VI LP | 10% Owner | Jan 23, 2024 | Buy | $3.70 | 243,356 | 900,904 | 946,744 | Jan 25, 2024, 08:00 PM | |
| CALC | CalciMedica, Inc. | Sanderling Venture Partners VI LP | 10% Owner | Jan 23, 2024 | Buy | $3.70 | 194,472 | 719,935 | 435,148 | Jan 25, 2024, 08:00 PM | |
| CALC | CalciMedica, Inc. | Sanderling Venture Partners VI LP | 10% Owner | Jan 23, 2024 | Buy | $3.70 | 144,676 | 535,591 | 727,433 | Jan 25, 2024, 08:00 PM | |
| CALC | CalciMedica, Inc. | Sanderling Venture Partners VI LP | 10% Owner | Jan 23, 2024 | Buy | $3.70 | 3,920 | 14,512 | 21,602 | Jan 25, 2024, 08:00 PM | |
| CALC | CalciMedica, Inc. | Sanderling Venture Partners VI LP | 10% Owner | Jan 23, 2024 | Buy | $3.70 | 28,744 | 106,410 | 30,292 | Jan 25, 2024, 08:00 PM | |
| CALC | CalciMedica, Inc. | Sanderling Venture Partners VI LP | 10% Owner | Jan 23, 2024 | Buy | $3.70 | 51,032 | 188,920 | 114,260 | Jan 25, 2024, 08:00 PM | |
| CALC | CalciMedica, Inc. | Sanderling Venture Partners VI LP | 10% Owner | Jan 23, 2024 | Buy | $3.70 | 13,184 | 48,807 | 27,609 | Jan 25, 2024, 08:00 PM | |
| PCRX | Pacira Pharmaceuticals, Inc. | Sanderling Venture Partners VI LP | 10% Owner | Mar 07, 2013 | Sale | $12.67 | 104,591 | 1,324,889 | 1,372,169 | Apr 15, 2013, 08:10 PM | |
| PCRX | Pacira Pharmaceuticals, Inc. | Sanderling Venture Partners VI LP | 10% Owner | Mar 11, 2013 | Sale | $27.86 | 348,951 | 9,721,775 | 559,453 | Apr 15, 2013, 08:10 PM | |
| PCRX | Pacira Pharmaceuticals, Inc. | Sanderling Venture Partners VI LP | 10% Owner | Jan 24, 2013 | Sale | $18.93 | 500,000 | 9,465,000 | 882,562 | Apr 15, 2013, 08:09 PM | |
| PCRX | Pacira Pharmaceuticals, Inc. | Sanderling Venture Partners VI LP | Director | Mar 19, 2013 | Sale | $27.27 | 84,589 | 2,306,831 | 462,422 | Mar 20, 2013, 09:32 PM | |
| PCRX | Pacira Pharmaceuticals, Inc. | Sanderling Venture Partners VI LP | Director | Mar 18, 2013 | Sale | $28.69 | 165,411 | 4,745,234 | 530,497 | Mar 20, 2013, 09:32 PM | |
| PCRX | Pacira Pharmaceuticals, Inc. | Sanderling Venture Partners VI LP | 10% Owner | Mar 07, 2013 | Sale | $12.67 | 104,591 | 1,324,889 | 1,372,169 | Mar 11, 2013, 06:59 PM | |
| PCRX | Pacira Pharmaceuticals, Inc. | Sanderling Venture Partners VI LP | 10% Owner | Mar 11, 2013 | Sale | $27.86 | 348,951 | 9,721,775 | 559,453 | Mar 11, 2013, 06:59 PM | |
| PCRX | Pacira Pharmaceuticals, Inc. | Sanderling Venture Partners VI LP | 10% Owner | Jan 24, 2013 | Sale | $18.93 | 500,000 | 9,465,000 | 882,562 | Jan 25, 2013, 05:04 PM | |
| PCRX | Pacira Pharmaceuticals, Inc. | Sanderling Venture Partners VI LP | 10% Owner | Feb 08, 2011 | Buy | $7.00 | 221,478 | 1,550,346 | 184,131 | Feb 10, 2011, 09:55 PM | |
| PCRX | Pacira Pharmaceuticals, Inc. | Sanderling Venture Partners VI LP | 10% Owner | Feb 08, 2011 | Buy | $7.00 | 231,895 | 1,623,265 | 46,379 | Feb 10, 2011, 09:55 PM |
Menu